Tobramycin sulfate and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tobramycin sulfate (tobramycin sulfate) and Methotrexate (methotrexate sodium). Common drug interactions include stevens-johnson syndrome among females and petit mal epilepsy among males.

The phase IV clinical study analyzes what interactions people have when they take Tobramycin sulfate and Methotrexate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tobramycin sulfate?

Tobramycin sulfate has active ingredients of tobramycin sulfate. eHealthMe is studying from 581 Tobramycin sulfate users. Check the latest studies of Tobramycin sulfate.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,314 Methotrexate users. Check the latest studies of Methotrexate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

13 people who take Tobramycin sulfate and Methotrexate together, and have interactions are studied.

Tobramycin sulfate and Methotrexate drug interactions.

What are the common drug interactions of Tobramycin Sulfate and Methotrexate, by gender? *:

female:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Blood ph decreased
  5. Cardiac failure
  6. Cardiomegaly (increased size of heart than normal)
  7. Cerebral haemorrhage (bleeding within the brain)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Clostridial infection (infectious conditions by clostridium bacteria)
  10. Death

male:

  1. Petit mal epilepsy (absence seizure)
  2. Cardiac failure
  3. Haemolytic anaemia (anaemia due to haemolysis)
  4. Pharyngolaryngeal pain
  5. Pleural infection (infection of membrane of lungs)
  6. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  7. Sore throat (pain or irritation of the throat)
  8. Diarrhoea
  9. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  10. Hypokalaemia (low potassium)

What are the common drug interactions of Tobramycin Sulfate and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Petit mal epilepsy (absence seizure)
  2. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Respiratory distress (difficulty in breathing)

10-19:

  1. Haemolytic anaemia (anaemia due to haemolysis)

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure
  2. Diarrhoea
  3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  4. Hypokalaemia (low potassium)
  5. Hypoproteinaemia (too little prolactin circulating in the blood)
  6. Pneumonia
  7. Renal failure (kidney dysfunction)
  8. Vomiting
  9. Blood bilirubin increased
  10. Pharyngolaryngeal pain

50-59:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

60+:

  1. Blood ph decreased
  2. Cardiac failure
  3. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Respiratory depression (respiration has a rate below 12 breaths)
  6. Visual acuity reduced (reduced clearness of vision)
  7. Weight increased
  8. Cardiomegaly (increased size of heart than normal)
  9. Clostridial infection (infectious conditions by clostridium bacteria)
  10. Death

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 30.77%
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 23.08%
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 15.38%
  4. Agitation (state of anxiety or nervous excitement): 2 people, 15.38%
  5. Anaesthesia: 2 people, 15.38%
  6. Bacterial Infection: 2 people, 15.38%
  7. Bleeding Disorders: 2 people, 15.38%
  8. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 15.38%
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 2 people, 15.38%
  10. Dyspnea (difficult or laboured breathing): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Tobramycin sulfate and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tobramycin sulfate and Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tobramycin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tobramycin sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tobramycin sulfate and methotrexate sodium (the active ingredients of Tobramycin sulfate and Methotrexate, respectively), and Tobramycin sulfate and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: